| |
| |
|
| Insider
Information: |
Momtazee James C |
| Relationship: |
|
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
183,342 |
|
|
Indirect Shares
|
9,293,278 |
|
|
| Direct
Value |
$5,425,434 |
|
|
|
Indirect Value
|
$49,497,130 |
|
|
| Total
Shares |
9,476,620 |
|
|
| Total
Value |
$54,922,563 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -20.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Accuride Corp |
ACW |
Director |
|
0 |
2005-10-12 |
7,850,213 |
Premium* |
|
|
Alliance Healthcare Services |
AIQ |
Director |
2007-05-07 |
0 |
2007-03-16 |
1,443,065 |
Premium* |
|
|
Jazz Pharmaceuticals Inc |
JAZZ |
Director |
2013-08-13 |
17,315 |
2012-01-11 |
0 |
Premium* |
|
|
Entellus Medical Inc |
ENTL |
Director |
2018-02-28 |
0 |
2017-07-14 |
0 |
Premium* |
|
|
Pra Health Sciences, Inc. |
PRAH |
Director |
2021-07-01 |
0 |
2019-08-13 |
0 |
Premium* |
|
|
Bridgebio Pharma, Inc. |
BBIO |
Director |
2021-12-29 |
88,491 |
2020-02-12 |
0 |
Premium* |
|
|
Roivant Sciences Ltd. |
ROIV |
|
2024-04-24 |
77,536 |
2022-07-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACW |
Accuride Corp |
Director |
– • • |
2005-04-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
12,765,600 |
|
- |
|
| ACW |
Accuride Corp |
Director |
– • – |
2005-10-05 |
4 |
S |
$13.25 |
$56,633,813 |
I/I |
(4,274,250) |
8,491,350 |
|
- |
|
| ACW |
Accuride Corp |
Director |
– • – |
2005-10-12 |
4 |
S |
$13.25 |
$8,495,065 |
I/I |
(641,137) |
7,850,213 |
|
- |
|
| AIQ |
Alliance Healthcare Servi... |
See Footnotes 1, 2 and 3 |
– • – |
2006-11-27 |
4 |
S |
$5.41 |
$43,240,000 |
I/I |
(8,000,000) |
27,144,570 |
0 |
- |
|
| AIQ |
Alliance Healthcare Servi... |
See Footnotes 1, 2 and 3 |
– • – |
2006-11-29 |
4 |
S |
$5.41 |
$6,486,000 |
I/I |
(1,200,000) |
25,944,570 |
0 |
- |
|
| AIQ |
Alliance Healthcare Servi... |
See Footnotes 1, 2 and 3 |
– • – |
2007-03-16 |
4 |
S |
$6.25 |
$153,134,406 |
I/I |
(24,501,505) |
1,443,065 |
0 |
- |
|
| AIQ |
Alliance Healthcare Servi... |
Director |
– • – |
2007-05-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,811 |
20,811 |
0 |
- |
|
| AIQ |
Alliance Healthcare Servi... |
Director |
– • – |
2007-05-07 |
4 |
D |
$9.24 |
$192,294 |
D/D |
(20,811) |
0 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2012-01-11 |
4 |
D |
$48.60 |
$540,189 |
D/D |
(11,115) |
13,885 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2012-01-11 |
4 |
OE |
$8.23 |
$540,250 |
D/D |
25,000 |
22,884 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2012-01-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,885) |
0 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2012-01-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,885 |
|
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2012-08-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
16,135 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2012-08-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
16,135 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2013-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
18,385 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2013-08-13 |
4 |
S |
$81.86 |
$87,590 |
D/D |
(1,070) |
17,315 |
0 |
- |
|
| ENTL |
Entellus Medical Inc |
Director |
– • – |
2017-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
3,750 |
3,750 |
0 |
- |
|
| ENTL |
Entellus Medical Inc |
Director |
– • – |
2018-02-28 |
4 |
D |
$24.00 |
$90,000 |
D/D |
(3,750) |
0 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
Director |
– • – |
2019-08-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,443 |
1,443 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2020-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
8,491 |
8,491 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
Director |
– • – |
2020-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,748 |
3,191 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
Director |
– • – |
2021-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
330 |
3,521 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
Director |
– • – |
2021-07-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,521) |
0 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2021-12-29 |
4 |
B |
$14.50 |
$1,160,000 |
D/D |
80,000 |
88,491 |
2.39 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
Director |
– • – |
2022-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
3,923 |
3,923 |
0 |
- |
|
37 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
